Nu Skin Enterprises (NUS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 335,630 | 386,911 | 426,399 | 357,246 | 289,354 |
| Marketable Securities | 8,413 | 11,346 | 11,847 | 10,880 | 14,371 |
| Receivables | 50,378 | 53,282 | 33,196 | 31,199 | 35,464 |
| Inventories | 275,891 | 295,821 | 253,454 | 249,936 | 265,256 |
| TOTAL | $740,166 | $799,237 | $777,789 | $714,337 | $706,392 |
| Non-Current Assets | |||||
| PPE Net | 453,604 | 464,535 | 464,587 | 444,732 | 454,537 |
| Intangibles | 276,894 | 286,562 | 182,601 | 178,507 | 179,455 |
| Other Non-Current Assets | 298,342 | 144,112 | 164,895 | 136,469 | 165,459 |
| TOTAL | $1,028,840 | $895,209 | $812,083 | $759,708 | $799,451 |
| Total Assets | $1,769,006 | $1,694,446 | $1,589,872 | $1,474,045 | $1,505,843 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 27,500 | 69,455 | 77,840 | 82,727 | 67,849 |
| Accounts payable and accrued liabilities | 38,979 | 47,617 | 50,341 | 41,261 | 28,832 |
| Accrued Expenses | 290,281 | 322,583 | 319,189 | 275,023 | 310,916 |
| TOTAL | $356,760 | $439,655 | $447,370 | $399,011 | $407,597 |
| Non-Current Liabilities | |||||
| Long Term Debt | 334,461 | 361,008 | 310,790 | 334,165 | 181,745 |
| Other Non-Current Liabilities | 202,496 | 111,916 | 127,116 | 76,799 | 90,880 |
| TOTAL | $536,957 | $472,924 | $437,906 | $410,964 | $272,625 |
| Total Liabilities | $893,717 | $912,579 | $885,276 | $809,975 | $680,222 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 55,547 | 55,361 | 52,751 | 52,569 | 55,819 |
| Common Shares | 91 | 91 | 91 | 91 | 91 |
| Retained earnings | 1,727,772 | 1,635,751 | 1,609,168 | 1,558,589 | 1,493,941 |
| Other shareholders' equity | -85,118 | -79,539 | -66,012 | -84,245 | -71,332 |
| TOTAL | $875,289 | $781,867 | $704,596 | $664,070 | $825,621 |
| Total Liabilities And Equity | $1,769,006 | $1,694,446 | $1,589,872 | $1,474,045 | $1,505,843 |